Olema Pharmaceuticals, Inc.OLMANASDAQ
Loading
Year-over-year net income growth rate
Latest
-9.11%
↑ 59% vs avg
Percentile
P50
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-22.31%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -9.11% |
| Q3 2025 | 3.58% |
| Q2 2025 | -44.08% |
| Q1 2025 | 9.47% |
| Q4 2024 | 2.86% |
| Q3 2024 | -13.74% |
| Q2 2024 | 1.90% |
| Q1 2024 | -15.68% |
| Q4 2023 | -24.51% |
| Q3 2023 | -7.00% |
| Q2 2023 | 28.96% |
| Q1 2023 | -8.05% |
| Q4 2022 | -15.22% |
| Q3 2022 | 30.85% |
| Q2 2022 | -42.67% |
| Q1 2022 | -6.43% |
| Q4 2021 | -22.16% |
| Q3 2021 | -7.97% |
| Q2 2021 | -6.96% |
| Q1 2021 | -51.41% |
| Q4 2020 | -29.16% |
| Q3 2020 | -219.77% |
| Q2 2020 | -44.89% |
| Q1 2020 | -66.47% |
| Q4 2019 | 0.00% |